NYSE: EBS · Drug Manufacturers - Specialty & Generic
Over the past week, Emergent Biosolutions (EBS) pulled in about 53 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 32% bullish but is deeply split: X runs 50% bullish while News sits at just 17%. Wall Street is more constructive, with 2 of 3 analysts rating EBS a buy.
There is little buzz around EBS this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 67% buy share sits next to a crowd that ranges from News at 17% to X at 50%. No other tracker puts the two side by side.
Across 3 analysts the consensus is a Strong Buy: 2 buy calls against 1 sell, with an average 12-month price target of $11.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 35 points above the crowd average of 32%, the professionals are more constructive than retail. The split is inside the crowd: X reads 50% bullish while News sits at 17%, a 33-point spread that single-source trackers miss.
Over the 30-day window, Emergent Biosolutions (EBS) buzz held subdued around 18.7 while the price drifted up 13.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.2M shares. Updated Oct 10, 2026. Over the last 7 trading days, EBS gained 10.8%. Buzz activity in the recent week averaged 29.7 and was variable, swinging between 14.0 and 45.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 5 of the 13 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for EBS and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live EBS sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (2 / 0 / 1) |
| Crowd bullish (7d) | 32% |
| Avg price target | $11.00 |
| Most bullish source | X, 50% |
| Most bearish source | News, 17% |
| Sentiment spread | 33 pts |
| Mentions (7d) | 53 |
| Market cap | $349.2M |
| P/E · Forward P/E | n/a · 23.0 |
| EPS · Beta | -$3.40 · 2.3 |
| Revenue (TTM) | $770.2M · -23% margin |
| Industry | Drug Manufacturers - Specialty & Generic |
Based on aggregated sentiment from Reddit, X and News sources, Emergent Biosolutions (EBS) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 32% bullish across 3 active sources. Those sources contribute 53 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Emergent Biosolutions (EBS) is fairly quiet with 7 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 28% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bearish on Emergent Biosolutions (EBS), averaging 32% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 50% bullish and News at 17%, a 33-point spread. On the professional side, 2 of 3 analysts rate EBS a buy.
Of the 3 analysts covering Emergent Biosolutions (EBS), 2 rate it a buy, 0 a hold and 1 a sell, for a strong buy consensus. The average price target is $11.00. That puts the street ahead of the crowd, which averages 32% bullish.
Emergent Biosolutions (EBS)'s cross-source average is bearish at 32% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. Reddit reads 28% bullish, X reads 50% bullish and news coverage is the most negative at 17% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Emergent Biosolutions (EBS) at 32% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. The most bearish reading is news at 17% bullish. 3-day activity momentum is rising across Reddit and X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 28 mentions (53% of total volume). News contributes 18 mentions and Reddit contributes 7 mentions. The cross-source average is bearish at 32% bullish, while reddit and x and news show rising 3-day activity. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. EBS's sell signal at 93/100 conviction reflects a bearish cross-source average at 32% bullish. Source readings are split: 2 sources lean bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The EBS sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key